Sun Pharmaceutical gains on plan to buy GSK’s Opiates business in Australia

03 Mar 2015 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 937.90, up by 14.05 points or 1.52% from its previous closing of Rs. 923.85 on the BSE.

The scrip opened at Rs. 936.20 and has touched a high and low of Rs. 945.80 and Rs. 936.00 respectively. So far 21,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 965.90 on 05-Feb-2015 and a 52 week low of Rs. 552.50 on 14-Mar-2014.

Last one week high and low of the scrip stood at Rs. 945.80 and Rs. 861.10 respectively. The current market cap of the company is Rs. 1,94,683.00 crore.

The promoters holding in the company stood at 63.65% while Institutions and Non-Institutions held 26.55% and 9.80% respectively.

Sun Pharmaceutical Industries will buy GSK’s Opiates business in Australia. GlaxoSmithKline (GSK) and Sun Pharmaceutical Industries have announced that their respective wholly owned subsidiaries have reached an agreement related to GSK’s Opiates business in Australia. The current GSK Opiates business including related manufacturing sites in Latrobe (Tasmania) and Port Fairy (Victoria) and its portfolio of opiates products along with inventory will transfer to a subsidiary of Sun Pharma.

The product portfolio consists of poppy-derived opiate raw materials that are primarily used in the manufacture of analgesics for the treatment of moderate to severe pain. All employees from both sites will also be offered employment by Sun with the Opiates business.

The transaction will allow GSK to simplify its operations in Australia and allow it to focus on delivering its innovative product portfolio that will be central to the company’s growth strategy in this country.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

 

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×